41
Growth Score in past quarter
pts
Heat Score 41 in past quarter
-22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
3024999
SYGNAMAP uses spatial omics and AI to develop precision diagnostics and therapeutics for complex diseases.
- Shoba Sharma: Co-Founder
About the Company
SYGNAMAP leverages spatial omics and computational imaging to identify critical pathways underlying the fundamental pathologies of diseases. The company develops precision diagnostics and therapeutics for complex diseases, including metabolic diseases and progressive organ failure. SYGNAMAP's MSI-DeepPath computational platform quantifies
spatially distinct metabolite abundances with histopathologic features, enabling precision medicine through AI-driven spatial omics.